Acemannan is a polydispersed ␤-(1,4)-linked acetylated mannan with antiviral properties. It is an immunomodulator, and studies in our laboratory have shown that it causes activation of macrophages. In the presence of IFN␥, acemannan induced apoptosis in RAW 264.7 cells. These cells exhibited chromatin condensation, DNA fragmentation, and laddering characteristic of apoptosis. The induction of apoptosis by acemannan and IFN␥ does not seem to be mediated by nitric oxide, since N-nitro-L-arginine methyl ester, the nitric oxide inhibitor, had no effect. Acemannan in the presence of IFN␥ also inhibited the expression of bcl-2. These results suggest that acemannan in the presence of IFN␥ induces apoptosis in RAW 264.7 cells through a mechanism involving the inhibition of bcl-2 expression.
IFN␥ does not seem to be mediated by nitric oxide, since N-nitro-L-arginine methyl ester, the nitric oxide inhibitor, had no effect. Acemannan in the presence of IFN␥ also inhibited the expression of bcl-2. These results suggest that acemannan in the presence of IFN␥ induces apoptosis in RAW 264.7 cells through a mechanism involving the inhibition of bcl-2 expression.
Apoptosis is a form of cell death that can be induced in susceptible cells by a wide variety of normal physiological stimuli as well as by deleterious environmental conditions. Some of the characteristic features of apoptosis include cytoplasmic shrinkage associated with membrane blebbing, followed by chromatin condensation and DNA fragmentation. Although all cells undergoing apoptosis exhibit these changes sequentially, it is believed that these events occur independently and under the control of separate and distinct metabolic pathways. Anticancer drugs are known to induce apoptosis in target cells (Searle et al., 1975; Sen and D'Incalci, 1992; Skladanowski and Konopa, 1993) , and although the interaction of these drugs with the cellular targets has been studied extensively, the mechanism by which these chemotherapeutic agents induce apoptosis is unclear (Dive and Wyllie, 1993) . One of the mechanisms seems to be by the activation of the sphingomyelin signal transduction pathway (Hannun, 1994; Kolesnick and Golde, 1994) .
Acemannan is a polydispersed ␤-(1,4)-linked mannan isolated from Aloe vera (Manna and McAnalley, 1993; Paquet and Pierard, 1996) . It is believed to be an immunostimulant and is conditionally licensed by the United States Department of Agriculture (USDA) for the treatment of fibrosarcoma in dogs and cats (Drapier et al., 1988; King et al., 1995) . Preliminary trials indicate that acemannan immunostimulant maybe an effective adjunct to surgery and radiation therapy in the treatment of canine and feline sarcomas. However, little is known about the mechanism of action of this compound. Mannans with significant antitumor activity have been isolated from yeasts and it has been shown that they act mainly by the activation of macrophages. Acemannan causes the activation of mouse macrophages and, in the presence of IFN␥, induces nitric oxide synthase in RAW 264.7 cells (Ramamoorthy et al., 1996) . In this article, we report that acemannan in the presence of IFN␥ also induces apoptosis in RAW 264.7 cells and that this induction seems to be by a nitric-oxide-independent mechanism.
washed with ice-cold PBS (1 ϫ ϭ 137 mM NaCl, 2.6 mM KCl, 10 mM Na 2 HPO 4 , and 1.8 mM KH 2 PO 4 ), pelleted by centrifugation, lysed in 0.5 ml of lysis buffer (10 mM EDTA, 50 mM Tris-Cl, pH 8, 1% SDS and 250 g/ml proteinase K) and incubated for 1 hr at 50°. Nucleic acids were extracted from the digested lysates by the phenol/chloroform extraction method (Ausubel et al., 1987; Damle et al., 1993) and then precipitated overnight with cold 100% ethanol at Ϫ20°. Nucleic acid precipitates were centrifuged for 15 min at 2000 ϫ g, vacuum dried, and resuspended in 20 l of Tris/EDTA buffer and incubated with 250 g/ml of RNase at 65°for 5 min to remove RNA. Electrophoresis of the resulting DNA was carried out in 2% agarose gels and DNA was visualized by exposure to UV light and photographed.
Cell staining for apoptotic nuclear morphology. RAW 264.7 cells were plated at a density of 2 ϫ 10 6 cells/60-mm dish and allowed to adhere for 4 hr. Cells were then treated with media alone or the combination of acemannan (50 g/ml) and IFN␥ (1 unit/ml) for a period of 36 hr and then stained as described (Pelfrey et al., 1995) . Briefly, at 36 hr after treatment, the cells were removed and pelleted by centrifugation at 500 ϫ g. The supernatant was discarded and the cell pellet was resuspended in 250 l of Hoechst 33342 dye (stock solution 1 mg/ml in dimethylsulfoxide, diluted 1:200 in PBS). Cells were incubated for 15 min at 37°followed by gentle addition of propidium iodide (20 g/ml diluted in PBS). The cells were then pelleted, thoroughly resuspended in a very small volume of PBS (15-25 l) and examined in a fluorescent microscope (Olympus BH2 compound microscope; Olympus, Tokyo, Japan) at 100 ϫ using UV excitation filters. The Hoechst 33342 dye stains morphologically normal nuclei a diffuse pale blue, whereas apoptotic nuclei demonstrate condensed, smaller, and very intensely bright blue nuclei. The cell is stained a diffuse pink with propidium iodide once the membrane of the cell has sustained damage associated with death. Apoptotic cells demonstrate brightly pink condensed nuclei whereas necrotic cells remain diffuse pink.
Thymidine release assay. The thymidine release assay for solubilized low-molecular-weight DNA was performed as a modification of the assay described by Matzinger (1991) . Briefly, cells at a concentration of 1 ϫ 10 5 cells/ml were labeled with 10 Ci/ml [ 3 H]thymidine (86.90 Ci/mmol; DuPont-New England Nuclear, Boston, MA) at 37°for 2 hr. The cells were then washed and plated into 96-well microplates at a cell concentration of 1 ϫ 10 5 /ml in media alone, acemannan (50 g/ml), IFN␥ (1 unit/ml) or a combination of the two for a period of 36 hr. At the end of the incubation period, the cells and their medium were aspirated onto glass fiber filters (Pharmacia Biotech, Piscataway, NJ). In principle, intact chromatin DNA binds to the filter, whereas the fragmented and solubilized DNA does not and thus will be washed away. The filters were washed, dried, and counted in a liquid scintillation counter (Beckman LS3801; Beckman Instruments, Palo Alto, CA). Data are expressed as percentage release of incorporated [ 3 H]thymidine compared with mean control counts Ϯ standard error. Typically, the control wells (no acemannan or IFN␥) had total counts of 20,000-30,000 cpm.
Assay for NO synthesis. Synthesis of NO was determined by assay of culture supernatants for NO 2 Ϫ , a stable reaction product of NO with molecular oxygen. RAW 264.7 cells were seeded into 12-well tissue culture plates at a density of 10 6 cells per well. Cells were treated with acemannan (50 g/ml), IFN␥ (1 unit/ml) or the combination of the two, and NO 2 Ϫ production was measured after 48 hr (Stuehr and Marletta, 1987) . Briefly, 50 l of culture supernatant was incubated with an equal volume of Greiss reagent (0.5% sulfanilamide, 0.05% N-(1-naphthyl)-ethylenediamine dihydrochloride in 2.5% H 3 PO 4 ) in 96-well tissue culture plate for 10 min at room temperature. The absorbance at 550 nm was measured in a ELISA plate reader (Dynatech Labs, Chantilly, VA) along with NaNO 2 standards. The concentration of protein was determined using the bicinchoninic acid reagent from Pierce (Rockford, IL) (Bradford, 1976) .
SDS-PAGE and immunoblotting. RAW 264.7 cells were treated with media alone, acemannan (50 g/ml), IFN␥ (1 unit/ml) or a combination of the two for a period of 36 hr. At the end of 36 hr, cell monolayers were washed with ice-cold PBS and lysed in a buffer containing 10 mm Tris, pH 7.4, 150 mm NaCl, 1 mM EDTA, 1 mM EGTA, 0.2 mM sodium orthovanadate, 1% Triton X-100, 0.5% NP-40, and 0.2 mM phenylmethylsulfonyl fluoride. SDS-PAGE (12.5%) was conducted under denaturing, reducing conditions, according to Laemmli (1970) . Proteins were transferred onto a PVDF membrane with 0.2-m pores (Immobilon-P; Millipore, Bedford, MA) using 15% methanol, 25 mM Tris and 192 mM glycine, pH 8.3. The membrane was blocked for 1 hr at room temperature with 5% nonfat dry milk in Tris-buffered saline (25 mM Tris, pH 7.5, 150 mM NaCl, 0.1% Tween 20) and then incubated with mouse anti-bcl-2 monoclonal antibody (1:5000 dilution; Santa Cruz Biochemicals, Santa Cruz, CA) for 1 hr at room temperature. The membrane was washed with Tris-buffered saline and then subsequently incubated for 1 hr with anti-mouse IgG conjugated to alkaline phosphatase (Sigma Chemical). After washing, the membrane was equilibrated in alkaline phosphatase buffer (100 mM Tris, pH 9.5, 100 mM NaCl and 5 mM MgCl2) and developed in a solution of 167.5 g/ml nitroblue tetrazolium and 167.5 g/ml 5-bromo-4-chloro-3-indoyl phosphate in alkaline phosphatase buffer.
Isolation of RNA, reverse transcription, and PCR amplification. RAW 264.7 cells (2 ϫ 10 6 ) were seeded into 60-mm tissue culture dishes and incubated overnight at 37°in 5% CO 2 in air to allow for adherence. Cells were incubated with media alone, acemannan, IFN␥, or the combination of the two, for varying time periods. At the end of the incubation period, the stimulus was removed and the cells were rinsed with PBS. The cells were then scraped off the plate and mRNA isolated as described below.
RNA was isolated using the MicroFasttrack kit (InVitrogen, San Diego, CA). The cell pellet was suspended in 1 ml of lysis buffer containing 200 mM NaCl, 200 mM Tris, pH 7.5, 1.5 mM MgCl 2 , 2% SDS and protein/RNase degrader. The cell lysate was passed through an oligo dT cellulose column and poly(A) ϩ RNA was eluted using a buffer containing 10 mM Tris-Cl, pH 7.5, in DEPC-treated water (Sigma). RNA was precipitated using 0.15 M sodium acetate and 0.1 mg glycogen carrier and 2.5 volumes of ethanol. The RNA pellet was washed once with 80% ethanol containing RNasin (0.2 units/l of DEPC-treated water), dried and resuspended in 11.5 l of DEPC-treated water.
cDNA was synthesized by reverse transcription using oligo dT primers and avian myeloblastosis virus reverse transcriptase (Searle et al., 1975; Saiki et al., 1985) . About 1.5 M oligo dT primer was annealed to 1 g of poly(A) ϩ RNA and extended with avian myeloblastosis virus reverse transcriptase (13.3 units/l) in a buffer containing 50 mM Tris⅐HCl, pH 8.3, 75 mM KCl, 3 mM MgCl 2 , 0.5 mM deoxy-NTP mix, and RNase inhibitor (1 unit/l) at 42°for 1 hr. The reaction was terminated by incubation at 80°for 10 min. The cDNA produced was diluted (1:4) with DEPC-treated water and amplified as described below.
PCR amplification was carried out with 10 ng of the cDNA in a buffer containing deoxy-NTPs (0.2 mM), MgCl 2 (2.5 mM), and 1.5 units of Taq polymerase (Promega, Madison, WI). The PCR amplimers for mouse bcl-2 were upstream primer 5Ј-GAA GTG CCA TTG GTA CCT GC-3Ј and downstream primer 5Ј-GGT CAG ATG GAC ACA TGG TG-3Ј (Gonzalez-Garcia et al., 1994; Negrini et al., 1987; Oltvai et al., 1993) . The PCR amplimers for mouse G3PD were upstream primer 5Ј-TGA AGG TCG GTG TGA ACG GAT TTG GC-3Ј and downstream primer 5Ј-CAT GTA GGC CAT GAG GTC CAC CAC-3Ј (Sabath et al., 1990) . The primer set for G3PD was obtained from Clonetech Laboratories (Palo Alto, CA) while the primers for Fig. 2 . Acemannan in the presence of IFN␥ causes apoptosis in RAW 264.7 cells. RAW 264.7 cells were incubated with either media alone (A), or a combination of acemannan (50 g/ml) and IFN␥ (1 unit/ml) (B-D) for a period of 24 hr, 36 hr, or 48 hr. At the end of the specific time period, cells were harvested, stained with Hoechst 33342 dye and propidium iodide and examined in a fluorescent microscope at 100ϫ using DANS filters. The Hoechst 33342 dye stains morphologically normal nuclei a diffuse pale blue, whereas apoptotic nuclei demonstrate condensed, smaller and very intensely bright blue nuclei. The cell is stained a diffuse pink with propidium iodide once the membrane of the cell has sustained damage associated with death. Apoptotic cells demonstrate brightly pink condensed nuclei, whereas necrotic cells remain diffuse pink.
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at ASPET Journals on July 6, 2017 molpharm.aspetjournals.org bcl-2 were synthesized as oligonucleotides by the Gene Technologies Laboratory (Department of Biology, Texas A & M University, College Station, TX). The amplification was carried out in PTC 150 thermal cycler (MJ Research, Watertown, MA). The denaturation was at 94°( 1 min), the annealing temperature was 60°(2 min), and extension was at 72°(3 min) and this was cycled 30 times. The amplified products were analyzed on a 2% agarose gel (Ausubel et al., 1987) .
Southern Hybridization. The specificity of the products obtained by amplification of the cDNAs was verified by Southern analysis. The Southern transfer of amplified cDNA was from a 1.5% agarose gel run in Tris/borate/EDTA (1ϫ ϭ 89 mM Tris, 89 mM boric acid, 2 mM EDTA, pH 8.0) buffer to a nylon membrane (MagnaGraph; Fisher Scientific, Pittsburgh, PA) according to the manufacturer's protocol. The EcoRV/BamHI fragment of G3PD and the 379-bp fragment of bcl-2 were used as probes. The hybridization probes were radiolabeled with [ 32 P]deoxy-ATP (3000 Ci/mmol, DuPont-New England Nuclear, Boston, MA) with a random primer labeling kit (Boehringer-Mannheim Biochemicals, Indianapolis, IN).
Southern hybridization was performed at 65°in 5 ϫ standard saline/ phosphate/EDTA (1ϫ ϭ 150 mM NaCl, 10 mM NaH 2 PO 4 , and 10 mM EDTA, pH 7.4)/2% SDS with 10 g/ml salmon sperm DNA (Ausubel et al., 1987) . Mouse bcl-2 probe (the 865-bp mouse bcl-2 gene cloned into pBluescript KS) was also used for southern analysis; this was a gift from Dr. Stanley J. Korsmeyer.
The PCR fragments obtained using mouse G3PD primers and the bcl-2 primers were cloned into pcTR11 vector (TA cloning kit from InVitrogen) and the sequence verified by restriction analysis and dideoxy sequencing (Ausubel et al., 1987) .
Annexin V staining. RAW 264.7 cells were plated at a density of 2 ϫ 10 6 cells/60 mm dish and allowed to adhere for 4 hr. Cells were then treated with media alone or the combination of acemannan (50 g/ml) and IFN␥ (1 unit/ml) for a period of 36 hr and then stained as described (Vermes et al., 1995; Boersma et al., 1997) . Briefly, cells were washed with PBS, pelleted by centrifugation at 500 ϫ g and the cell pellet was resuspended in 1ϫ binding buffer containing 10 mM HEPES, pH 7.4, 140 mM NaCl and 2.5 mM CaCl 2 . To a 100-l aliquot of the cell suspension, 10 l of propidium iodide (50 g/ml) was added, followed by 5 l of Annexin V [FITC-conjugated Annexin V from PharMingen (San Diego, CA)] and cells were incubated in the dark for 15 min at room temperature. Flow cytometry was performed on a FACScan flow cytometer (Becton Dickinson, San Jose, CA) and the following parameters were measured: forward light scatter, side light scatter, phosphatidylethanolamine fluorescence (575-590 nm) and FITC fluorescence (515-545 nm). Forward light scatter and side light scatter were measured in linear mode, whereas phosphatidylethanolamine and FITC were measured in a logarithmic mode and a total of 10,000 events were analyzed. Analysis of the data was performed using the CellQuest software (Becton Dickinson Immunocytometry Systems, San Jose, CA).
Results
Acemannan in the presence of IFN␥ causes apoptosis in macrophages. RAW 264.7 cells were treated with acemannan in the presence and absence of IFN␥ for a period of 48 hr and the cells were then analyzed for the occurrence 4 . L-NAME does not inhibit the apoptosis caused by acemannan in the presence of IFN␥ RAW 264.7 cells were treated with acemannan and IFN␥ in the presence and absence of L-NAME for a period of 48 hr. DNA fragmentation was then analyzed in these samples using the thymidine release assay. Data are expressed as percent DNA fragmentation: 100 ϫ (1 Ϫ cpm in experimental group/cpm of untreated cells) ϩ mean Ϯ standard error and are representative of three independent experiments.
418
Ramamoorthy and Tizard at ASPET Journals on July 6, 2017 molpharm.aspetjournals.org of apoptosis by DNA fragmentation assay, gel electrophoresis, and propidium staining. Analysis of the DNA by agarose gel electrophoresis indicated the occurrence of apoptosis. The DNA laddering characteristic of apoptosis was observed in cells treated with acemannan and IFN␥ (Fig. 1A) . Acemannan by itself or IFN␥ (1 unit/ml) did not cause any DNA laddering. In cells treated with acemannan (50 g/ml) and IFN␥ (1 unit/ml), DNA fragmentation occurred around 36 hr after treatment, and by 48 hr, most of the cells had undergone apoptosis (Fig. 1B) . Staining of the cells with Hoechst 33342 followed by propidium iodide also indicates that apoptosis is occurring in RAW 264.7 cells treated with acemannan and IFN␥ (Fig. 2) .
Cells undergoing apoptosis lose membrane phospholipid asymmetry and expose phosphatidylserine on the outer leaflet of the plasma membrane. The detection of phosphatidylserine exposure by annexin V during the redistribution of the plasma membrane has been shown to be a general and early marker of apoptosis. Annexin V staining of RAW 264.7 cells treated with acemannan and IFN␥ showed that apoptosis occurred in these cells at 18 hr after treatment and by 36 hr about 65% of the cells had undergone apoptosis (Fig. 3) . All these results suggest that acemannan in the presence of IFN␥ causes apoptosis in RAW 264.7 cells.
Apoptosis caused by acemannan in the presence of IFN␥ is not NO-dependent. Acemannan in the presence of IFN␥ causes the induction of the inducible nitric oxide synthase in RAW 264.7 cells (Ramamoorthy et al., 1996) . Nitric oxide is known to cause apoptosis in some cell types and this could account for the apoptosis observed in these cells. To verify this, an inhibitor of nitric oxide production L-NAME (Sigma) was used. RAW 264.7 cells were treated with ace- Fig. 5 . Time course of bcl-2 expression. RAW 264.7 cells were treated with acemannan (50 g/ml) and IFN␥ (1 unit/ml) for various time periods. Total cell lysates were prepared and subjected to SDS-PAGE (12% gel for bcl-2 and 10% gel for actin) blotted on to PVDF membranes and probed (A) anti-bcl-2 antibody and (B) anti-actin antibody. The results shown are representative of three independent experiments. A, lane 1, the positive control (M1 cell lysate from PharMingen); lane 2 represents treatment with media alone and lanes 3-8 represent treatment with acemannan and IFN␥ for 6 hr, 12 hr, 18 hr, 24 hr, 30 hr, and 36 hr, and lane 9 represents the migration of the molecular weight markers. B, lane 1, represents media alone; lanes 2-7, treatment with acemannan and IFN␥ for 6 hr, 12 hr, 18 hr, 24 hr, 30 hr and 36 hr; lane 8; the migration of the molecular weight markers. 
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at ASPET Journals on July 6, 2017 molpharm.aspetjournals.org mannan and IFN␥ in the presence and absence of L-NAME and occurrence of apoptosis was studied at the end of 48 hr using the thymidine release assay. Acemannan by itself did not cause any significant DNA fragmentation, but the combination of the two caused a 3-4-fold increase in the fragmentation of DNA. L-NAME inhibited the production of nitric oxide by cells treated with acemannan and IFN␥ (data not shown) but did not inhibit DNA fragmentation in these cells, which suggests that nitric oxide may not be involved in this induction of apoptosis caused by the combination of acemannan and IFN␥ (Fig. 4) .
Effect of acemannan and IFN␥ on the expression of bcl-2. Acemannan in the presence of IFN␥ caused a decrease in the expression of bcl-2. RAW 264.7 cells were treated with acemannan in the presence of IFN␥ for various time periods and the expression of bcl-2 was studied by Western analysis. The expression of bcl-2 could be detected in all cells at 12-hr, 18-hr, and 24-hr post-treatment. However, bcl-2 expression could not be detected in cells treated with acemannan and IFN␥ for 30 hr and the effect continued even at 36 hr after treatment (Fig. 5) . This was observed only when the cells were treated with acemannan in the presence of IFN␥. Acemannan and IFN␥ by themselves did not cause any decrease in the expression of bcl-2 (Fig. 6) To verify if the inhibition of bcl-2 occurred at the level of transcription, we examined the steady state mRNA levels of bcl-2.
RAW 264.7 cells were treated with acemannan in the presence and absence of IFN␥ for varying time periods, at the end of which mRNA was isolated and the level of bcl-2 was studied using RT-PCR. The bcl-2 gene was expressed in all cells at 12 hr after treatment, but by 24 hr, the gene seems to be turned off in cells treated with acemannan and IFN␥ and continues to be so even at 48 hr after treatment (Fig. 7) . Thus acemannan in the presence of IFN␥ causes the induction of apoptosis in RAW 264.7 cells by a mechanism involving bcl-2.
Discussion
Acemannan, a ␤-(1,4)-linked acetylated mannan, has several important therapeutic properties, including acceleration of wound healing, inhibition of inflammation, and antiviral effects. It has also been shown to have antitumor activity; injection of acemannan has been shown to offer increased immune protection against implanted malignant tumor cells (Merriam et al., 1995) . Animals that recovered from the Norman murine sarcoma transplant rejected subsequent tumor transplants. However it is unclear how acemannan exerts this wide variety of effects and we believe that some of these effects are mediated through the macrophages.
Apoptosis, or programmed cell death, is believed to be an intrinsic death program that cells activate; thus, they actively contribute to their own deaths. The nucleus undergoes a relatively characteristic metamorphosis during apoptosis, first chromatin condensation, then nuclear condensation (Pelfrey et al., 1995) . This characteristic feature of DNA fragmentation and laddering was observed in RAW 264.7 cells treated with acemannan and IFN␥. Murine macrophages are extremely sensitive to the induction of apoptosis by inhibitors of macromolecular synthesis. Many cancer chemotherapeutic agents, such as dactinomycin, doxorubicin, and cycloheximide, have been shown to cause apoptosis in mouse peritoneal macrophages (Lewis et al., 1995) . RAW 264.7 cells treated with acemannan (50 g/ml) and IFN␥ (1 unit/ml) undergo the classical morphological changes associated with apoptosis. DNA fragmentation and the characteristic DNA laddering was observed in these cells. However, the mechanism by which this apoptosis is induced is not very clear. The transcriptional activator interferon regulatory factor 1 has been shown to play a critical role in the induction of apoptosis (Tanaka et al., 1994; Tamura et al., 1995) . Because apoptosis could be induced by acemannan only in the presence of IFN␥, it is quite likely that it involves the activation of interferon regulatory factor 1. However more stud- Fig. 7 . Acemannan in the presence of IFN␥ causes a decrease in the level of bcl-2 mRNA. RAW 264.7 cells were incubated media alone, acemannan (50 g/ml), IFN␥ (1 unit/ml), or the combination of the two for the indicated time periods. mRNA was isolated and reverse transcribed using oligo dT primers. Identical amounts of the cDNA were amplified by PCR in two separate reactions using primers for either bcl-2 or G3PD. The bcl-2 product was electrophoresed on a 2% agarose gel while the G3PD product was analyzed on a 1.2% agarose gel. The amount of bcl-2 PCR product used for electrophoresis was 3 times that of G3PD. 
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Acemannan in the presence of IFN␥ causes the induction of nitric oxide synthase in RAW 264.7 cells. Nitric oxide has been shown to induce apoptosis in these cells (Messmer et al., 1995) . However the induction of apoptosis by acemannan does not seem to be mediated by nitric oxide, because L-NAME had no effect.
Expression of bcl-2 was inhibited in RAW 264.7 cells treated with acemannan and IFN␥ for a period of 36 hr. Members of the bcl-2 family (bcl-2, bcl-x, bax, etc.) play a prominent role in apoptosis or preventing it (Meikrantz et al., 1994; Kroemer et al., 1995; Merino et al., 1995; Wang et al., 1995) . They are important molecular switches. Overexpression of bcl-2 can delay or block growth factor withdrawal-induced apoptosis indicating that bcl-2 plays an important role in preventing cell death. However, bcl-2 does not prevent apoptosis of ciliary neurons after ciliary neurotrophic factor withdrawal suggesting that the effect of bcl-2 is context dependent. RAW 264.7 cells treated with acemannan (50 g/ml) and IFN␥ (1 unit/ml) do not express bcl-2 and this is when apoptosis is observed in these cells. These results suggest that acemannan in the presence of IFN␥ induces apoptosis in RAW 264.7 cells through a mechanism involving the inhibition of bcl-2 expression.
